Atlas Trials

Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex

Clinical trial NCT06004037 · COMPLETED

Trial details

NCT number
NCT06004037
Sponsor
LigaChem Biosciences, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nontuberculous Mycobacterium InfectionMycobacterium Abscessus Infection
Start date
2024-01-16
Primary completion
2025-09-15
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.